Researcher
Peter Vandenberghe
- Disciplines:Genetics, Systems biology, Medical imaging and therapy, Molecular and cell biology, Other paramedical sciences
Affiliations
- Department of Human Genetics (Department)
Member
From1 Apr 2009 → Today - Laboratory for Genetics of Malignant Disorders (Division)
Responsible
From1 Jan 2008 → Today
Projects
1 - 10 of 13 results
- Integrated PK/PM Model-based Medication Dosing Assist App(lication) in KlinischWerkStation (KWS). Validation Studies of Tacrolimus in (Solid) Organ TransplantationFrom1 Jan 2021 → TodayFunding: IOF - technology validation in lab
- Tracking Multiple Myeloma by low-pass sequencing of circulating cell free DNAFrom1 Mar 2019 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Circulating cell-free DNA as an alternative gateway to the genetic features of multiple myeloma and as a surrogate marker for disease burden in multiple myeloma.From1 Mar 2019 → TodayFunding: Nonprofit institution or equivalents
- Circulating cell-free DNA: a novel gateway to the genome of Hodgkin/Reed-Sternberg cells in Hodgkin Lymphoma?From1 Jan 2017 → 31 Dec 2020Funding: Foundations, funds and other with scientific goal
- Circulating cell-free DNA: a novel gateway to the genome of Hodgkin/Reed-Sternberg cells in Hodgkin Lymphoma?From1 Jan 2016 → 31 Dec 2019Funding: FWO research project
- The molecular pathogenesis of essential thrombocythemia: identification of novel signal transduction pathways and novel driver mutations.From1 Jan 2015 → 31 Dec 2018Funding: FWO research project
- Identification of recurrent genetic disorders in myeloproliferative neoplasms using an integrated genomics approach.From1 Jan 2011 → 30 Jun 2014Funding: Private funding of national origin - undefined
- Molecular genetics of mantle cell lymphoma.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project
- From individual cancer genes to integrated cancer pathways in childhood cancer.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project
- Deregulated signaling pathways in cancer: from genetic insights towards targeted therapy.From1 Oct 2010 → 30 Nov 2016Funding: BOF - Concerted Research Project from 1994
Publications
1 - 10 of 213 results
- Noninvasive prenatal testing detected acute myeloid leukemia in paucisymptomatic pregnant patient(2020)
Authors: Laura Yissel Rengifo, Lucienne Michaux, Johan Maertens, Thomas Tousseyn, Liesbeth Lenaerts, Joris Vermeesch, Peter Vandenberghe, Barbara Dewaele
Pages: 1924 - 1927Number of pages: 4 - Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma(2020)
Authors: Renate De Smedt, Julie Morscio, Lindy Reunes, Juliette Roels, Valentina Bardelli, Beatrice Lintermans, Wouter Van Loocke, Afonso Almeida, Laurence C Cheung, Rishi S Kotecha, et al.
Pages: 1685 - 1695Number of pages: 11 - Ultra-low depth sequencing of plasma cell DNA for the detection of copy number aberrations in multiple myeloma(2020)
Authors: Lieselot Buedts, Sanne Smits, Genevieve Ameye, Stefan Lehnert, Jia Ding, Michel Delforge, Joris Vermeesch, Nancy Boeckx, Thomas Tousseyn, Lucienne Michaux, et al.
Pages: 465 - 471Number of pages: 7 - In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy(2020)
Authors: Lukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, Pauline Biesemans, Julio Finalet Ferreiro, Koen Debackere, Peter Vandenberghe, Gregor Verhoef, Olivier Gheysens, Giorgio Cattoretti, et al.
Pages: 1751 - 1766Number of pages: 16 - The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants(2020)
Authors: Ana Rio-Machin, Tom Vulliamy, Nele Hug, Amanda Walne, Kiran Tawana, Shirleny Cardoso, Alicia Ellison, Nikolas Pontikos, Jun Wang, Hemanth Tummala, et al.
Number of pages: 12 - FER and FES tyrosine kinase fusions in follicular T-cell lymphoma(2020)
Authors: Koen Debackere, Jo-Anne van der Krogt, Thomas Tousseyn, Julio Antonio Finalet Ferreiro, Katrien Van Roosbroeck, Lukas Marcelis, Carlos Graux, Daan Dierickx, Genevieve Ameye, Peter Vandenberghe, et al.
Pages: 584 - 588Number of pages: 6 - Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data(2020)
Authors: Gils Roex, Tom Feys, Yves Beguin, Tessa Kerre, Xavier Poire, Philippe Lewalle, Peter Vandenberghe, Dominique Bron, Sebastien Anguille
Number of pages: 15 - Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1(+) Leukemia (vol 19, pg 740, 2011)(2020)
Authors: Thomas Schmidt, Behzad Kharabi Masouleh, Sonja Loges, Sandra Cauwenberghs, Peter Fraisl, Christa Maes, Bart Jonckx, Kim De Keersmaecker, Maria Kleppe, Marc Tjwa, et al.
Pages: 135 - 136Number of pages: 2 - Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology(2020)
Authors: Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, et al.
Number of pages: 23 - Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study(2019)
Authors: Charlotte Maggen, Daan Dierickx, Pieternella Lugtenburg, Annouschka Laenen, Elyce Cardonick, Roman Smakov, Mar Bellido, Alvaro Cabrera-Garcia, Mina Mhallem Gziri, Michael J Halaska, et al.
Pages: E551 - E561Number of pages: 11